Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivonne Nel

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cells|June 25, 2025
Characterization of Disseminated Tumor Cells (DTCs) in Patients with Triple-Negative Breast Cancer (TNBC)Anne Eckardt, Ivonne Nel, Laura Weydandt, et al.
Plos One|April 22, 2016
Circulating Tumor Cell Composition in Renal Cell CarcinomaIvonne Nel, Thomas C Gauler, Kira Bublitz, et al.
Plos One|December 6, 2014
Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC)Patrick Weller, Ivonne Nel, Philipp Hassenkamp, et al.
Cancers|March 6, 2021
FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex VivoLuzie Brückner, Annika Reinshagen, Ngoc Anh Hoang, et al.
Biomarkers in Medicine|August 16, 2014
IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinomaIvonne Nel, Hideo A Baba, Frank Weber, et al.
Translational Oncology|August 3, 2013
Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinomaIvonne Nel, Hideo A Baba, Judith Ertle, et al.
Scientific Reports|November 3, 2023
Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotypeBenjamin Wolf, Laura Weydandt, Nadja Dornhöfer, et al.
BMC Cancer|March 11, 2018
CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinomaAnke Schlüter, Patrick Weller, Oliver Kanaan, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current ProgramsAndreas Schneeweiss, Sara Y Brucker, Hanna Huebner, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cells|June 25, 2025
Characterization of Disseminated Tumor Cells (DTCs) in Patients with Triple-Negative Breast Cancer (TNBC)Anne Eckardt, Ivonne Nel, Laura Weydandt, et al.
Plos One|April 22, 2016
Circulating Tumor Cell Composition in Renal Cell CarcinomaIvonne Nel, Thomas C Gauler, Kira Bublitz, et al.
Plos One|December 6, 2014
Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC)Patrick Weller, Ivonne Nel, Philipp Hassenkamp, et al.
Cancers|March 6, 2021
FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex VivoLuzie Brückner, Annika Reinshagen, Ngoc Anh Hoang, et al.
Biomarkers in Medicine|August 16, 2014
IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinomaIvonne Nel, Hideo A Baba, Frank Weber, et al.
Translational Oncology|August 3, 2013
Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinomaIvonne Nel, Hideo A Baba, Judith Ertle, et al.
Scientific Reports|November 3, 2023
Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotypeBenjamin Wolf, Laura Weydandt, Nadja Dornhöfer, et al.
BMC Cancer|March 11, 2018
CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinomaAnke Schlüter, Patrick Weller, Oliver Kanaan, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current ProgramsAndreas Schneeweiss, Sara Y Brucker, Hanna Huebner, et al.
Pageof 2